$3.45
-0.06-1.71%
At Close: -
$3.50
0.051.45%
After Hours: 4:41 PM EDT
15 minutes delayed
Autolus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Autolus Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.22 | $-0.19 | -15.8 % |
Mar 2024 | 2024-05-16 | $-0.24 | $-0.05 | -380.0 % |
Dec 2023 | 2024-03-14 | $-0.45 | $-0.25 | -80.0 % |
Sep 2023 | 2023-11-02 | $-0.26 | $-0.25 | -4.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $0 | $60.00K | -100.0 % |
Mar 2024 | 2024-05-16 | $10.09M | $25.00M | -59.6 % |
Sep 2023 | 2023-11-02 | $406.00K | $450.00K | -9.78 % |
Jun 2023 | 2023-08-03 | $0 | $140.00K | -100.0 % |
Autolus Therapeutics (AUTL) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.22, which missed the estimate of $-0.19.
The Actual Revenue was $0K, which missed the estimate of $60K.
Browse earnings estimates, EPS, and revenue on all stocks.